• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cell Therapeutics Inc

+ Add to Watchlist

CTIC:US

3.0500 USD 0.0800 2.56%

As of 20:10:00 ET on 04/15/2014.

Snapshot for Cell Therapeutics Inc (CTIC)

Open: 3.1600 Day's Range: 2.8700 - 3.2000 Volume: 4,405,095
Previous Close: 3.1300 52wk Range: 0.9700 - 4.2500 1-Yr Rtn: +177.27%

Stock Chart for CTIC

No chart data available.
  • CTIC:US 3.0500
  • 1D
  • 1M
  • 1Y
3.1300
Interactive CTIC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CTIC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4713
Est. EPS (USD) (12/2014) -0.3920
Est. PEG Ratio -
Market Cap (M USD) 456.34
Shares Outstanding (M) 149.62
30 Day Average Volume 4,830,183
Price/Book (mrq) 7.5690
Price/Sale (ttm) 11.4046
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CTIC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CTIC

Cell Therapeutics, Inc. is a biopharmaceutical company which provides medical research services. The Company develops and commercializes clinical treatment and drugs for various cancers such as ovarian, brain, neck, and breast.

James A BiancoPresident/CEO/Co-FounderLouis A BiancoExec VP:Finance/Co-Founder
Jack W SingerVP:Global Medical Affairs
More Company Profile & Key Executives for CTIC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil